Methylhydroquinone

Methylhydroquinone

SCHEMBL2870489

COC.Cc1cc(O)ccc1O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ HSD17B1 P14061 1/20 0.50
▸ HSD17B2 P37059 1/20 0.50
▸ PDE10A Q9Y233 1/20 0.50
▸ ESR1 P03372 8/20 0.48
▸ ESR2 Q92731 8/20 0.48
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ CA14 Q9ULX7 1/20 0.47
▸ AR P10275 1/20 0.45
▸ TLR8 Q9NR97 1/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylhydroquinone SCHEMBL6657815 0.98 TP53 (0.52) TP53TDP1MAOBHSD17B1HSD17B2
Methylhydroquinone SCHEMBL29364957 0.92 — —
Methylhydroquinone SCHEMBL36349 0.92 — —
Methylhydroquinone SCHEMBL10426478 0.92 TP53 (0.62) TP53TDP1MAOBHSD17B1HSD17B2
Methylhydroquinone SCHEMBL537277 0.90 TP53 (0.59) TP53TDP1HSD17B1HSD17B2PDE10A
Methylhydroquinone SCHEMBL612972 0.90 TP53 (0.59) TP53TDP1HSD17B1HSD17B2PDE10A
Methylhydroquinone SCHEMBL30471824 0.90 TP53 (0.59) TP53TDP1MAOBHSD17B1HSD17B2
Methylhydroquinone SCHEMBL11664779 0.90 TP53 (0.59) TP53TDP1MAOBHSD17B1HSD17B2
Methylhydroquinone SCHEMBL27680187 0.90 TP53 (0.59) TP53TDP1MAOBHSD17B1HSD17B2
Methylhydroquinone SCHEMBL4280911 0.90 TP53 (0.59) TP53TDP1HSD17B1HSD17B2PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3356320-A1 METHOD FOR THE SYNTHESIS OF OLIGOMERS OF ACRYLIC ACID Arkema France (FR) 2018-08-08 — — EP disclosed
US-9353043-B2 Preparation of (meth)acrylic esters of polyalkoxy-containing alcohols BASF SE (DE) 2016-05-31 — — US disclosed
US-20150232409-A1 PREPARATION OF (METH)ACRYLIC ESTERS OF POLYALKOXY-CONTAINING ALCOHOLS BASF SE (DE) 2015-08-20 — — US disclosed
US-8399225-B2 Process for preparing urethane-containing (meth)acrylic esters BASF SE (DE) 2013-03-19 — — US disclosed
US-20100291640-A1 PROCESS FOR PREPARING URETHANE-CONTAINING (METH)ACRYLIC ESTERS BASF SE (DE) 2010-11-18 — — US disclosed
US-5096938-A Acrylated polyester resins, coatings BASF AKTIENGESELLSCHAFT (DE) 1992-03-17 — — US disclosed
US-5053551-A PROCESS FOR THE PRODUCTION OF ALDEHYDES BY HYDROFORMYLATION DAVY MCKEE (LONDON) LIMITED (GB) 1991-10-01 — — US disclosed
EP-0313559-B1 PROCESS FOR THE PRODUCTION OF ALDEHYDES BY HYDROFORMYLATION DAVY McKEE (LONDON) LIMITED (GB) 1991-08-28 — — EP disclosed
US-4950809-A REACTING ARYL KETONE OR ALDEHYDE WITH PERACETIC ACID RHONE-POULENC CHIMIE (FR) 1990-08-21 — — US disclosed
US-4792636-A DEGASSING LIQUID HYDROFORMYLATION PRODUCT MEDIUM WHICH CONTAINS RHODIUM COMPLEX HYDROFORMYLATION CATALYST DAVY MCKEE (LONDON) LIMITED (GB) 1988-12-20 — — US disclosed
EP-0093550-B1 INHIBITED MONOMERIC COMPOSITIONS OF POLYOL(ALLYL CARBONATE), METHOD FOR THEIR PREPARATION AND METHOD FOR THEIR POLYMERIZATION PPG INDUSTRIES, INC. (US) 1986-01-29 — — EP disclosed
US-4057586-A Process for the manufacture of hydroquinone dimethyl ethers HOECHST AKTIENGESELLSCHAFT (DT) 1977-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232409-A1 PREPARATION OF (METH)ACRYLIC ESTERS OF POLYALKOXY-CONTAINING ALCOHOLS ADH1A, ADH1C, AKT1 TP53 3747/4885TDP1 3625/4885MAOB 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback